ArticleMolecular cancer therapeutics2022

Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors.

Tomomi M Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.